Two-Week pill test aims to slow aggressive breast tumors before surgery
NCT ID NCT05659563
Summary
This study tested whether a new drug called giredestrant or the standard drug tamoxifen was better at slowing the growth of early breast cancer in premenopausal women. 92 women took one of the pills daily for just 15 days before their scheduled surgery. Researchers compared tumor samples taken before and after treatment to see which drug more effectively reduced a marker of cancer cell growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopital Europeen Georges Pompidou
Paris, Paris, France
-
Hospital Arnau de Vilanova de Valencia
Valencia, Valencia, 46015, Spain
-
Hospital Beata Maria Ana
Madrid, Madrid, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, Spain
-
Hospital Clínic i Provincial de Barcelona
Barcelona, Barcelona, Spain
-
Hospital Clínico Universitario Virgen de la Arrixaca
Murcia, Murcia, Spain
-
Hospital General Universitario Dr. Balmis
Alicante, Alicante, 03010, Spain
-
Hospital Universitari Dexeus
Barcelona, Barcelona, Spain
-
Hospital Universitari Sant Joan de Reus
Reus, Tarragona, Spain
-
Hospital Universitario Clínico San Cecilio de Granada
Granada, Granada, 18016, Spain
-
Hospital Universitario La Paz
Madrid, Madrid, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Spain
-
Hospital Universitario Reina Sofía
Córdoba, Cordoba, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Sevilla, 41013, Spain
-
Hospital Universitario de León
León, Spain
-
Hôpital Tenon AP-HP
Paris, France
-
Institut Català d' Oncologia Badalona
Badalona, Barcelona, Spain
-
Instituto Valenciano de Oncología
Valencia, Spain
Conditions
Explore the condition pages connected to this study.